For help on how to get the results you want, see our search tips.
43 results
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Steglatro
ertugliflozin, opinion date: 16/09/2021, Positive, Last updated: 30/09/2021 -
List item
Summary of opinion: Velactis
cabergoline, opinion date: 05/12/2019, Negative, Last updated: 06/12/2019 -
List item
Summary of opinion: Rabitec
Rabies vaccine (live, oral) for foxes and raccoon dogs, opinion date: 23/01/2020, Positive, Last updated: 24/01/2020 -
List item
Summary of opinion: Clynav
Salmon pancreas disease vaccine (recombinant DNA plasmid), opinion date: 20/02/2020, Positive, Last updated: 21/02/2020 -
List item
Summary of opinion: Zulvac BTV
Bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3), opinion date: 20/05/2020, Positive, Last updated: 25/05/2020 -
List item
Summary of opinion: Frontpro (previously known as Afoxolaner Merial)
afoxolaner, opinion date: 09/09/2021, Positive, Last updated: 10/09/2021 -
List item
Summary of opinion: Cytopoint
lokivetmab, opinion date: 09/09/2020, Positive, Last updated: 11/09/2020 -
List item
Summary of opinion: Leucofeligen FeLV/RCP
feline calicivirosis, feline viral rhinotrachieitis, feline infectious enteritis (feline panleucopenia) vaccine (live), feline leukaemia vaccine (inactivated), opinion date: 25/05/2020, Positive, Last updated: 25/05/2020 -
List item
Summary of opinion: Galvus
vildagliptin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Elebrato Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Temybric Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Rapiscan
regadenoson, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Siklos
hydroxycarbamide, opinion date: 22/07/2021, Negative, Last updated: 23/07/2021 -
List item
Summary of opinion: Credelio
lotilaner, opinion date: 19/01/2022, Positive, Last updated: 21/01/2022 -
List item
Summary of opinion: Senshio
ospemifene, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Segluromet
ertugliflozin, metformin hydrochloride, opinion date: 16/09/2021, Positive, Last updated: 17/09/2021 -
List item
Summary of opinion: Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
vildagliptin, metformin, opinion date: 21/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Advocate
imidacloprid, moxidectin, opinion date: 16/03/2022, Positive, Last updated: 18/03/2022 -
List item
Summary of opinion: Elonva
corifollitropin alfa, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Yescarta
axicabtagene ciloleucel, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: NovoSeven
eptacog alfa (activated), opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Bydureon
exenatide, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Retsevmo
selpercatinib, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Opdivo
nivolumab, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021